Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma

Background: Platinum-containing doublet chemotherapy regimens are generally considered the standard first-line systemic therapy for recurrent or metastatic (R/M) nasopharyngeal cancer (NPC). Gemcitabine (GEM) plus cisplatin (CDDP) has become a standard therapy based on a phase 3 study in several cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Yuri, Enokida, Tomohiro, Okano, Susumu, Fujisawa, Takao, Ito, Kazue, Tahara, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575747/
https://www.ncbi.nlm.nih.gov/pubmed/33117701
http://dx.doi.org/10.3389/fonc.2020.571304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575747/
https://www.ncbi.nlm.nih.gov/pubmed/33117701
http://dx.doi.org/10.3389/fonc.2020.571304

Ejemplares similares